LB-100
CAS No. 1632032-53-1
LB-100( LB100 )
Catalog No. M12454 CAS No. 1632032-53-1
LB-100 (LB100) is a potent serine/threonine protein phosphatase 2A (PP2A) inhibitor; exhibits inhibitory effect in HCC cell lines Huh-7, HepG2, Hep3B, and SNU-449 with mean IC50 of 10 uM.
LB-100 (LB100) is a potent serine/threonine protein phosphatase 2A (PP2A) inhibitor; exhibits inhibitory effect in HCC cell lines Huh-7, HepG2, Hep3B, and SNU-449 with mean IC50 of 10 uM.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
Size | Price / USD | Stock | Quantity |
2MG | 64 | In Stock |
|
5MG | 97 | In Stock |
|
10MG | 178 | In Stock |
|
25MG | 284 | In Stock |
|
50MG | 422 | In Stock |
|
100MG | 618 | In Stock |
|
200MG | Get Quote | In Stock |
|
500MG | Get Quote | In Stock |
|
1G | Get Quote | In Stock |
|
Biological Information
-
Product NameLB-100
-
NoteResearch use only, not for human use.
-
Brief DescriptionLB-100 (LB100) is a potent serine/threonine protein phosphatase 2A (PP2A) inhibitor; exhibits inhibitory effect in HCC cell lines Huh-7, HepG2, Hep3B, and SNU-449 with mean IC50 of 10 uM.
-
DescriptionLB-100 (LB100) is a potent serine/threonine protein phosphatase 2A (PP2A) inhibitor; exhibits inhibitory effect in HCC cell lines Huh-7, HepG2, Hep3B, and SNU-449 with mean IC50 of 10 uM; synergistically enhances the activity of doxorubicin and induces expression of HIF-1α and VEGF; significantly enhances tumor growth inhibition by cisplatin in vivo.Brain Cancer Phase 1 Clinical.
-
In Vitro——
-
In Vivo——
-
SynonymsLB100
-
PathwayCancer
-
TargetBrain Cancer
-
RecptorPP2A
-
Research AreaCancer
-
IndicationBrain Cancer
Chemical Information
-
CAS Number1632032-53-1
-
Formula Weight268.3089
-
Molecular FormulaC13H20N2O4
-
Purity>98% (HPLC)
-
SolubilityH2O: ≥ 48 mg/mL; DMSO: < 2.9 mg/mL
-
SMILESO=C(C1C(O2)CCC2C1C(N3CCN(C)CC3)=O)O
-
Chemical Name7-Oxabicyclo[2.2.1]heptane-2-carboxylic acid, 3-[(4-methyl-1-piperazinyl)carbonyl]-, (1R,4S)-rel-
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Bai XL, et al. Mol Cancer Ther. 2014 Aug;13(8):2062-72.
2. Chang KE, et al. Mol Cancer Ther. 2015 Jan;14(1):90-100.
3. Gordon IK, et al. Mol Cancer Ther. 2015 Jul;14(7):1540-7.
molnova catalog
related products
-
Disitertide
Disitertide (P144) is a TGF-β1 antagonist peptide.
-
Perifosine
A oral bioavailable alkylphospholipid that displays significant antiproliferative activity in vitro and in vivo in several human tumor model; acts as an Akt inhibitor and a PI3K inhibitor.
-
LB-100
LB-100 (LB100) is a potent serine/threonine protein phosphatase 2A (PP2A) inhibitor; exhibits inhibitory effect in HCC cell lines Huh-7, HepG2, Hep3B, and SNU-449 with mean IC50 of 10 uM.